Expansion Opportunity Rapid US footprint growth and a Jacksonville expansion indicate a strong sales window for pharmacy partners and hospital systems in the US. Target pharmacy chains, regional hospital networks, and integrated delivery pharmacists to leverage the new US presence and supply chain investments.

Aurum Platform Push Launch of the Aurum Printer and Platform suggests demand for faster, automated compounding. Focus on hospital pharmacies and retail pharmacy networks seeking scalable, compliant automation to reduce turn times and labor costs, highlighting speed gains and regulatory alignment.

Funding Momentum Significant Series A funding from HealthCap, Sandwater, Tesi, and Lifeline Ventures signals investor confidence and capacity to scale. Leverage this momentum to approach strategic partners, potential co-development agreements, and customers prioritizing vendor stability and long-term roadmaps.

Regulatory Readiness ISO 13485 certification and compliance by design approach position CurifyLabs as a trusted supplier for regulated environments. Position the company to healthcare buyers requiring proven quality systems, supplier quality agreements, and audit-ready workflows.

Clinical Adoption Upcoming clinical use in Europe and the US, with non-sterile compounding focus, implies an early network of reference sites. Target multi-site pharmacies, hospital systems, and regional health networks seeking validated case studies and measurable efficiency gains.